VivoSeq
Other

Bronchoscopy

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Bronchoscopy is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

12/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

25

clinical trials

Completed16 · 64%
Unknown status4 · 16%
Withdrawn2 · 8%
Terminated1 · 4%
Suspended1 · 4%
Recruiting1 · 4%

Trial Activity

25 trials

Remifentanil Use in Pediatric Rigid Bronchoscopy
Completed··Phase 4·NCT01947114·40 enrolled
Xylometazoline During Nasal Flexible Bronchoscopy
Completed··N/A·NCT03424889·148 enrolled
1% vs. 2 % Lignocaine for Flexible Bronchoscopy
Completed··N/A·NCT02701179·500 enrolled
Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy
Completed··Phase 4·NCT01470170·173 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)